1. Home
  2. ESPR vs DNUT Comparison

ESPR vs DNUT Comparison

Compare ESPR & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.13

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Logo Krispy Kreme Inc.

DNUT

Krispy Kreme Inc.

HOLD

Current Price

$3.23

Market Cap

627.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
DNUT
Founded
2008
1937
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Food Chains
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
731.9M
627.5M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
ESPR
DNUT
Price
$3.13
$3.23
Analyst Decision
Strong Buy
Hold
Analyst Count
4
5
Target Price
$8.75
$4.15
AVG Volume (30 Days)
16.9M
2.5M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
60.71
N/A
EPS
N/A
N/A
Revenue
$403,135,000.00
$1,522,616,000.00
Revenue This Year
N/A
$0.55
Revenue Next Year
$12.81
$3.59
P/E Ratio
N/A
N/A
Revenue Growth
21.31
N/A
52 Week Low
$0.76
$2.58
52 Week High
$4.18
$5.73

Technical Indicators

Market Signals
Indicator
ESPR
DNUT
Relative Strength Index (RSI) 70.76 37.58
Support Level $2.37 $3.09
Resistance Level $3.18 $3.87
Average True Range (ATR) 0.05 0.22
MACD 0.07 -0.08
Stochastic Oscillator 96.38 2.25

Price Performance

Historical Comparison
ESPR
DNUT

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet-treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations world-wide. It derives maximum revenue from the U.S. segment.

Share on Social Networks: